IV Therapy and Wellness Clinic Selling — 60-Min Training

Two ways to run the hour: the compliance-first track versus the conversion-first track

Every clinic manager who sits down to build this training lands on one of two structures, and the choice determines what the room actually walks out doing on Monday. Understanding both — and why the hybrid beats either in isolation — is the first decision to make before you write a single agenda line.

Option A: the compliance-first track. You spend the bulk of the hour on intake, screening, contraindications, and scope of practice. The logic is defensible. IV hydration sits in a genuinely regulated space: infusion requires a licensed provider's order and administration by qualified clinical staff, state medical and nursing boards define who may insert a line and who may not, and patient-education-before-initiation is an explicit standard in the Infusion Nurses Society's Infusion Therapy Standards of Practice. Clinics that get this wrong don't lose a sale — they lose a license. A compliance-first hour typically allocates roughly 35 of the 60 minutes to intake mechanics, red-flag routing, and disclosure scripting, with the remaining 25 split between menu knowledge and a rushed membership pitch tacked onto the end.

The cost is predictable. Reps leave clinically careful and commercially timid. They screen beautifully, route red flags without hesitation, and then hand the patient a punch card at checkout and say "see you next time." The membership conversation never happens because it was the last thing on the agenda and the room ran out of time — which is exactly what happens in most 60-minute meetings.

Option B: the conversion-first track. You spend the hour on objection handling, savings math, and closing language. Roughly 40 minutes on the close, 20 on everything else. Reps leave confident, ask for the autopay enrollment at every checkout, and conversion numbers move within the week.

The cost here is worse, and it's slower to show up. A rep who has been drilled on closing but not on screening starts treating intake as a formality — a clipboard to get out of the way. That's the failure mode that produces the two most expensive outcomes in this business: an adverse reaction in a patient who was on a medication nobody asked about, and a one-star review describing a hard sell in a medical setting. Reviews are the entire top of funnel for a walk-in clinic. One "they pressured me while I was hooked up to an IV" review costs more revenue than a month of membership signups produces.

Option C: the sequenced hybrid — what this training actually runs. The resolution isn't a compromise on time allocation; it's a claim about causality. The disclosure conversation is not an obstacle to the close. It is the mechanism that produces the close. A patient who has just watched a rep slow down, name three specific contraindications, confirm their intake answers out loud, and volunteer "this isn't a substitute for your primary care doctor" has been given a reason to believe everything else that rep says — including the savings math ninety seconds later. Selling and screening are the same motion performed in order, not two competing agendas fighting over the same hour.

So the hybrid runs: 5 minutes on why walk-ins don't convert, 15 on intake, 10 on the menu walk, 10 on contraindication disclosure, 15 on membership math and the autopay close, 5 on commitments. Sixty minutes exactly. The compliance content isn't reduced — it's repositioned as the trust-building front half of a single sales conversation rather than a separate legal module the room tunes out.

How to decide which track your clinic needs this quarter

The hybrid is the default, but the weighting shifts based on what your clinic is actually failing at right now. Diagnose before you build the agenda — running a conversion-heavy hour at a clinic with a screening problem is how you accelerate toward a board complaint.

Pull three numbers before the meeting. First, your walk-in-to-member conversion rate: memberships sold divided by unique first-time visitors over the last 90 days. Second, your declined-service count: how many patients were routed to a provider and turned away or deferred. If that number is zero across a quarter of walk-ins, your reps are not screening — a healthy clinic declines or defers a small but nonzero share of patients, and a zero means the intake form is being treated as paperwork. Third, your review sentiment on sales pressure: read the last 50 public reviews and count any mention of upselling, pushiness, or being sold to during treatment.

If screening is the gap, push intake to 20 minutes and cut the math segment to 10. Spend the extra time on paired role-play where one manager plays a patient on a blood thinner or with a stated kidney condition, and the rep must catch it and route to the nurse without making the moment feel like an accusation. That awkwardness is the actual skill being trained — reps skip screening because routing feels rude, not because they don't know the rule.

If discipline is the gap — you're converting fine but reviews mention pressure — the hour becomes about subtraction. Drill the one-comeback rule and the three-drip rule. A rep who offers a second comeback after a patient says no has converted a maybe into a bad review. Practice the sentence that ends the attempt gracefully: "Totally fair — I'll email you the math, and it'll be here whenever you want it."

If close mechanics are the gap — good screening, clean reviews, flat membership numbers — the extra time goes to the tablet. Most reps who don't close aren't afraid of rejection; they've simply never done the arithmetic out loud in front of a patient and don't know what it sounds like. Have every rep run the math live, twice, in front of the room.

One more decision input: franchise versus independent. If you operate a franchise unit, your brand standards, membership tier names, credit rollover rules, and cancellation policy are set for you — the training's job is fidelity to that model, and reps must quote your actual policy verbatim. Independents have to write the policy before they can train the script, and the single most common independent mistake is training a savings pitch against a membership structure that doesn't actually save the patient money at their stated frequency.

The concrete numbers behind each path

Numbers make the case in the room better than any argument about philosophy. Run these live, with your clinic's real prices substituted for the ranges below.

Walk-in economics. Typical single-visit pricing in this category runs roughly $150–$200 for a basic Myers-style vitamin and mineral drip, $175–$250 for immunity or hangover-recovery formulations, and substantially higher for premium NAD+ protocols, which are commonly priced in the several-hundred-dollar range and scale with dose and duration. Add-ons — a glutathione push, a B12 or lipotropic intramuscular injection — sit in the low tens to roughly a hundred dollars each. A walk-in who buys one drip and one add-on is a two-to-three-hundred-dollar customer, once.

The repeat problem. The killer number in a walk-in clinic isn't average ticket, it's return rate. A transactional close — ring up, hand over a punch card, say goodbye — produces a customer who returns when they happen to remember you, which for most people is never, or once more in the following winter. Every dollar of acquisition cost you paid to get that person through the door is amortized over a single visit.

Membership economics. A monthly autopay membership priced in the range of a single-visit drip, give or take, changes the amortization completely. Work the arithmetic for a patient who told you on intake that they'd ideally come monthly:

• Single visit at your posted price, twelve times a year, is twelve times your posted price. At $200, that's $2,400 annually in cash-pay visits — assuming they actually come every month, which they won't without a commitment device.
• The same patient on a monthly membership priced below the single-visit rate pays that lower number twelve times, and the autopay itself is the commitment device that makes the twelve visits happen.
• Included monthly add-on credits — a B12 shot, a discounted glutathione push — stack real value onto the member side of the ledger without adding much marginal cost to you, because the consumable cost of a small IM injection is a fraction of its posted price.

The result you're aiming to show the patient is a savings figure they can hold in their head, plus credits they'd otherwise pay for separately. The result you're aiming to show your reps is duration: a member who stays most of a year is worth a multiple of a walk-in, and the multiple compounds because members refer at a much higher rate than one-time visitors. They've made an identity commitment, not just a purchase.

Ramp and training economics. The reason this is a manager-led hour rather than an LMS module is that live, manager-run playbook sessions with role-play produce faster behavior change than self-paced video. Reps adopt the language they've spoken out loud in front of peers, not the language they've watched. Budget the hour weekly for the first month after rollout, then biweekly.

Compensation math. Membership signups need their own incentive line, separate from drip revenue, or reps will optimize for the higher-ticket single drip. A flat spiff per signup plus a small monthly residual for as long as the member stays active is the structure that aligns the rep with retention rather than with the close alone. Set the residual window long enough that a rep who signs up a poor-fit patient who cancels in month two feels the difference. Post the board weekly: signups, active members retained, and declined services. Putting declines on the same board as signups is what signals that screening is not the opposite of selling.

Cost of the failure modes. Price them out loud. A single adverse event in an unscreened patient means an incident report, a possible board complaint, and legal exposure that dwarfs a year of membership revenue. A single credible "high-pressure sales in a medical setting" review depresses walk-in volume measurably in a business where local search reviews are the funnel. Both are cheap to prevent and expensive to survive.

Running the hour: sequencing, scripts, and what happens Monday

The agenda below is the sequence. Each block has a fixed output — a script memorized, a form filled, a number quoted — so nobody leaves with "good session" as the only takeaway.

Minutes 0–5: why walk-ins don't convert. Put the three failure modes on the whiteboard and name them. The *transactional close* — ring up, punch card, goodbye. The *over-sell* — pushing a premium protocol on a patient who hasn't been screened for it. The *menu dump* — reciting all fourteen drips until the patient freezes and picks the cheapest thing to escape. Every rep in the room has done all three this month. Naming them is what makes the rest of the hour feel like a fix rather than a lecture.

Minutes 5–20: the intake flow. Distribute the form and have reps fill it out on each other. The questions that matter: reason for visit; current medications and supplements, with explicit attention to blood thinners, diuretics, and immunosuppressants; known conditions, including kidney disease, cardiac conditions, hypertension, and pregnancy or nursing; last meal and fluid intake; prior IV therapy history; and — the commercially load-bearing question — *how often would you ideally want to feel the way you'll feel after today?* with options at once a year, monthly, and weekly. Finish with a signature line acknowledging that the contraindication disclosure was reviewed.

Coach that last question hard. A patient who answers "monthly" has pre-qualified themselves for a membership, and the rep's only remaining job at checkout is arithmetic. A patient who answers "once a year" should not get a membership pitch at all — pitching them is how you generate the pressure reviews. The intake form is doing lead qualification and clinical screening in the same pass.

Be explicit about the boundary: the form routes the patient to the clinical screen, it does not replace it. A licensed provider evaluates and orders; the form's job is to surface what the provider needs to see. Reps must never interpret a medication list themselves.

Spend the last five minutes of this block on paired role-play with a red-flag patient. The rep must catch the flag and say the routing sentence without apology: "Before we go further I want our nurse to take a look at one thing on here — that's standard, it'll take two minutes."

Minutes 20–30: the menu walk. The rule is three drips, never more: the one that matches their stated reason for visit, one tier above, one tier below. If the patient asks about a fourth, the answer is "let's get you started with what fits today, and we'll talk through the others at your follow-up."

Then read the never-say list aloud, slowly, because these are the sentences that generate regulatory and reputational risk:

• Never claim a drip will *cure* or *treat* a named condition — migraine, depression, chronic fatigue, or anything else. Wellness hydration is not a treatment claim, and unsupported medical claims are the fastest way to attract regulatory attention.
• Never promise anti-aging outcomes from a premium protocol. If patients ask, the honest framing is that some patients report feeling more energetic and mentally clear, and that the evidence base varies by ingredient.
• Never say "it's just vitamins, totally safe for anyone." It isn't. Dosing, renal function, and drug interactions all matter, which is the entire reason a provider screens.
• Never say "we don't really need to check your medications." There is no version of this sentence that is acceptable.
• Never pitch frequency before the patient has been cleared.
• Never name-drop a celebrity as social proof. It cheapens a clinical setting and invites exactly the wrong expectations.

Minutes 30–40: the disclosure script. Reps memorize this one; improvising is where claims get made. The shape: name the nurse who'll be doing the insertion, say that this is the same conversation every patient gets, state the main contraindications for the specific drip chosen, ask the patient to confirm nothing has changed since intake, describe the realistic side effects — a cool sensation at the site, a vitamin taste, occasional lightheadedness — and tell them explicitly that if anything feels wrong the nurse stops the drip, no pressure to push through. Then the line reps skip most often and regret most: this is hydration and wellness, not a substitute for their primary care physician, and if something medical is going on you'd rather they get cleared first.

Patient signs. Then, and only then, the transition sentence that bridges into the commercial half: "Great — she'll be with you in about five minutes. While we wait, can I show you how our members handle drips like this?"

Three prohibitions in this block. Don't rush the script — the deliberate pace is the trust signal, and rushing it converts a credibility-builder into throat-clearing. Don't skip the PCP line. And don't hand over a wall of legalese in place of the verbal walkthrough; documented verbal consent plus signature is a materially stronger position than a signature alone. Add-on offers — glutathione, B12 — happen after provider clearance and before the line goes in, one offer each, never during treatment.

Minutes 40–55: membership math and the autopay close. Every rep runs the arithmetic live on a tablet, using the patient's own answer to the frequency question. Quote today's single-visit price. Multiply by their stated cadence to get the annual cash-pay figure. Show the membership price and what it totals annually. State the savings as one number. Add the monthly credits as a second number. If total savings clear a meaningful threshold, anchor on savings; if they don't at that patient's frequency, anchor honestly on convenience and priority booking instead — never manufacture a savings story that the arithmetic doesn't support.

Then rehearse the objections, one comeback each:

• *"I'm not sure I'll come every month."* Answer with your actual credit-rollover and cancellation policy, stated accurately. Never describe a policy you don't have.
• *"That feels like a big commitment."* Frame the real minimum term honestly — if there's a three-month minimum, say three months; if it's month-to-month, that's a stronger answer anyway.
• *"Can I think about it?"* Offer to email the math, then convert the moment into a booked second visit while they're standing there.
• *"Can I get the member rate on today's drip if I sign up now?"* Yes, always, if your model allows it. Day-one enrollment is the cheapest acquisition you will ever run.

Hard cap at one comeback. A second attempt is pressure-selling, and in a clinical setting pressure-selling is a review liability, not a conversion technique.

Minutes 55–60: commitments. Three, written and posted at the front desk: every walk-in gets all six steps with no shortcuts; every red-flag intake goes to the provider before any drip is pitched, without awkwardness; and the membership math gets quoted at every checkout even when the rep is sure the patient won't bite, because the ask is the job. Close by scheduling a 30-minute ride-along per rep with the clinic manager inside the next two weeks — the training doesn't stick without one observed live rep.

Related questions

How often should this training be repeated?

Weekly for the first month after rollout, then biweekly, then monthly as maintenance. Script discipline decays fastest — reps drift back toward the menu dump and toward two comebacks within about three weeks of the last live session. Ride-alongs between sessions are what make the spacing work.

Should nurse-injectors attend, or only front-desk consultants?

Both, together. The handoff between consultant and injector is where disclosure gets dropped, each assuming the other covered it. Training them in the same room forces an explicit agreement about who says the contraindication script and when.

What if the clinic has no membership program yet?

Build the program before you train the pitch. Set the price, the included credits, the rollover rule, and the cancellation terms first. Training a savings script against a structure that doesn't actually save the patient money at their stated frequency produces reps who sound dishonest because they are.

Does this work for mobile IV service rather than a storefront?

Mostly. The six steps are identical, but intake and clinical screening move earlier — typically to booking — and the membership conversation happens after treatment by phone or app rather than at a physical checkout. The three-drip and one-comeback rules carry over unchanged.

How do you keep declines from feeling like lost revenue?

Put declined and deferred services on the same weekly board as signups, and treat a nonzero decline count as a passing grade. If reps see declines tracked as a quality metric rather than a miss, they stop rationalizing their way past red flags.

FAQ

What if a walk-in refuses to complete the intake form?

No intake, no infusion. Informed consent and patient education before initiation are baseline standards of infusion practice, not clinic preferences. The line that lands is simply: "We can't run a drip without it — that's the same rule at every clinic doing this properly." Almost nobody argues after that, and the ones who do are exactly the patients you don't want.

Should reps pitch premium NAD+ protocols to first-time patients?

No. Lead with a basic vitamin-and-mineral or immunity drip on visit one. Premium protocols enter the conversation at visit two or three, after the patient has a baseline experience to compare against and a provider has cleared the higher-dose protocol. Pitching the most expensive item to someone with no reference point is the over-sell failure mode by definition.

How do you handle a patient who wants weekly drips when the provider flags a concern?

Decline or defer, politely, and offer to proceed once they bring documentation from their physician. Log the decline. The rep should hear from the manager that this was the correct outcome — otherwise the next rep in that position will quietly not ask the question.

What's the right incentive structure for membership signups?

A flat spiff at signup plus a smaller monthly residual for as long as the member stays active. The residual is the important half: it makes a rep who enrolls a poor-fit patient feel the cancellation. Pay the spiff separately from drip revenue, or reps will optimize toward the higher single-visit ticket instead.

Can reps offer add-on injections and pushes aggressively?

One offer each, after provider clearance, before the line goes in — never during treatment and never after the second decline. Capping total upsells per visit is what keeps you out of menu-dump territory and off the review pages. A patient who is physically attached to an IV cannot easily leave a conversation, and selling into that is both an ethical and a reputational problem.

How is this different from selling med-spa packages like injectables?

Frequency and screening depth. IV wellness is higher frequency and lower per-ticket, so monthly membership math actually works; aesthetic injectables run on a quarterly cadence where package pre-purchase fits better than autopay. The intake and clearance floor is comparable — both are clinical settings — but the commercial structure diverges because the cadence does.

Sources

1. Infusion Nurses Society — https://www.ins1.org/
2. American Med Spa Association — https://americanmedspa.org/
3. Federal Trade Commission, Health Products Compliance Guidance — https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
4. U.S. Food and Drug Administration, Compounding and the FDA — https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
5. National Council of State Boards of Nursing — https://www.ncsbn.org/
6. MedlinePlus, Vitamin and Mineral Supplements — https://medlineplus.gov/dietarysupplements.html
7. National Institutes of Health, Office of Dietary Supplements — https://ods.od.nih.gov/
8. Federal Trade Commission, Negative Option Rule and subscription billing guidance — https://www.ftc.gov/legal-library/browse/rules/negative-option-rule

Related on PULSE

• [Cash-Pay Physical Therapy Package Selling — 60-Min Training](/knowledge/st290)
• [The Discovery Question Calibration Clinic — 60-Min Training](/knowledge/st0041)
• [The Gong Call-Review Clinic: Scoring Discovery in 60 Minutes](/knowledge/st0775)
• [The Sandler Selling System: Ready-to-Run Mini-Training for New Hires](/knowledge/st0794)
• [Selling with Stories: Narrative Structure Template for a 45-Minute Sales Workshop](/knowledge/st0792)
• [Leveraging Social Selling: Hands-On Activity Template for a Remote Team Session](/knowledge/st0787)